Evaluation of GS Junior and MiSeq next-generation sequencing technologies as an alternative to Trugene population sequencing in the clinical HIV laboratory
- 1 February 2015
- journal article
- research article
- Published by Elsevier in Journal of Virological Methods
- Vol. 212, 12-16
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Evaluation of a Benchtop HIV Ultradeep Pyrosequencing Drug Resistance Assay in the Clinical LaboratoryJournal of Clinical Microbiology, 2013
- Use of Four Next-Generation Sequencing Platforms to Determine HIV-1 Coreceptor TropismPLOS ONE, 2012
- Low-Cost Ultra-Wide Genotyping Using Roche/454 Pyrosequencing for Surveillance of HIV Drug ResistancePLOS ONE, 2012
- Analysis of high-depth sequence data for studying viral diversity: a comparison of next generation sequencing platforms using Segminator IIBMC Bioinformatics, 2012
- Study of Genotypic and Phenotypic HIV-1 Dynamics of Integrase Mutations During Raltegravir Treatment: A Refined Analysis by Ultra-Deep 454 PyrosequencingThe Journal of Infectious Diseases, 2012
- Challenges and opportunities in estimating viral genetic diversity from next-generation sequencing dataFrontiers in Microbiology, 2012
- Deep Molecular Characterization of HIV-1 Dynamics under Suppressive HAARTPLOS Pathogens, 2011
- Added Value of Deep Sequencing Relative to Population Sequencing in Heavily Pre-Treated HIV-1-Infected SubjectsPLOS ONE, 2011
- Tenofovir (TDF)-Selected or Abacavir (ABC)-Selected Low-Frequency HIV Type 1 Subpopulations During Failure with Persistent Viremia as Detected by Ultradeep PyrosequencingAIDS Research and Human Retroviruses, 2011
- Comparison of Automated Nucleic Acid Extraction Methods with Manual ExtractionThe Journal of Molecular Diagnostics, 2008